Summary Panel Discussion: Breaking Down Learnings From Pharmacology & PD Profiles to Understand In-Depth Insights for the Next Wave of ADCs

Bring your burning questions to this closing panel with all the seminar day’s presenters. With all ADC pharmacology topics up for discussion, hear the speakers delve into mechanistic and PD investigation for traditional and novel ADCs to model and characterize the next wave of ADCs heading to the clinic. 

Discussion Highlights Include:

• Exploring how pharmacology and mechanistic investigations can strengthen existing ADC knowledge and influence future ADC development
• Debating the therapeutic properties of conditionally active and masked ADCs to assess their ability to differentiate against traditional ADC profiles
• Discussing computational modeling and PK/PD approaches to tackle translational considerations for non-cytotoxic payload and novel format ADCs

Speakers:

Doug Kline

Senior Scientist II

Abbvie